autologous adipose tissue

Cell therapyexperimental

Clinical trial activity

11 trials · 11 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
1

Earliest trial started Aug 9, 2016 (NCT03399630)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2019

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetTissue restoration

    tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • autologous adipose tissue
  • autologous micro-fragmented adipose tissue
  • micro-fragmented adipose tissue

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07107399Phase 2/Phase 3 (Phase 3)Aug 5, 2025Cairo University
NCT06040957N/AJan 31, 2024University of Bologna
NCT05005000Phase 2Sep 15, 2021New York University
NCT04567732N/AOct 31, 2020University of Bologna
NCT04010526Phase 2Jul 31, 2019Aix-University of Marseille
NCT04164485Phase 1/Phase 2 (Phase 2)Jul 1, 2019Chinese Academy of Medical Sciences, Tsinghua University
NCT03771989N/AJan 1, 2019University of Copenhagen
NCT03242707N/AJul 1, 2018University of Southern California
NCT03167138Early Phase 1 (Phase 1)Jun 1, 2017Kessler Foundation
NCT03117608Phase 4Feb 24, 2017Lipogems International spa
NCT03399630N/AAug 9, 2016Aestique Medical Center
Showing 11 of 11 trials
Page 1 / 1

Organizations

Research & Development (11)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of BolognaAcademic/Hospital2212020
Aestique Medical CenterAcademic/Hospital1112016
Aix-University of MarseilleAcademic/Hospital1112019
Cairo UniversityAcademic/Hospital1112025
Chinese Academy of Medical SciencesAcademic/Hospital1112019
Kessler FoundationAcademic/Hospital1112017
Lipogems International spaFor profit1112017
New York UniversityAcademic/Hospital1112021
Tsinghua UniversityAcademic/Hospital1012019
University of CopenhagenAcademic/Hospital1112019
University of Southern CaliforniaAcademic/Hospital1112018
11 organizations
Page 1 / 1